Insulin resistance and hypertension
- PMID: 10423110
- DOI: 10.3109/10641969909061017
Insulin resistance and hypertension
Abstract
Insulin resistance, a common accompaniment of essential hypertension, increases cardiovascular risk both directly, and via its adverse effect on other cardiovascular risk factors. Decreasing insulin resistance by lifestyle modification including diet, weight loss, and physical exercise is an important component of therapy in all patients. With the exception of thiazide diuretics as monotherapy, the currently utilized classes of agent appear equally effective in lowering blood pressure in insulin resistant patients. Currently utilized agents do, however, differ substantially in their effect on insulin resistance and associated risk factors. Agents that diminish insulin resistance may have a rationale in treating insulin resistant patients with hypertension although a decisive recommendation about class of agent in this group of patients must await several prospective large scale trials currently underway. Lower intervention thresholds and lower therapeutic goals would appear to apply to hypertensive patients with insulin resistance especially in the presence of impaired glucose tolerance or overt diabetes mellitus.
Similar articles
-
Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system.Drugs. 2004;64(22):2537-65. doi: 10.2165/00003495-200464220-00004. Drugs. 2004. PMID: 15516153 Review.
-
Effects of blood-pressure-lowering treatment on outcome incidence in hypertension: 10 - Should blood pressure management differ in hypertensive patients with and without diabetes mellitus? Overview and meta-analyses of randomized trials.J Hypertens. 2017 May;35(5):922-944. doi: 10.1097/HJH.0000000000001276. J Hypertens. 2017. PMID: 28141660 Review.
-
[Hypertension and diabetes].Rev Med Liege. 2005 May-Jun;60(5-6):572-7. Rev Med Liege. 2005. PMID: 16041861 Review. French.
-
Hyperinsulinemia, insulin resistance, and hypertension.J Cardiovasc Pharmacol. 1994;24 Suppl 2:S39-49. J Cardiovasc Pharmacol. 1994. PMID: 7898093 Review.
-
Management of diabetes mellitus and insulin resistance in patients with cardiovascular disease.Am J Cardiol. 2003 Aug 18;92(4A):50J-60J. doi: 10.1016/s0002-9149(03)00616-7. Am J Cardiol. 2003. PMID: 12957327 Review.
Cited by
-
Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system.Drugs. 2004;64(22):2537-65. doi: 10.2165/00003495-200464220-00004. Drugs. 2004. PMID: 15516153 Review.
-
Hypertension and insulin disorders.Curr Hypertens Rep. 2002 Dec;4(6):477-82. doi: 10.1007/s11906-002-0029-y. Curr Hypertens Rep. 2002. PMID: 12419178 Review.
-
Association between insulin resistance and the development of cardiovascular disease.Cardiovasc Diabetol. 2018 Aug 31;17(1):122. doi: 10.1186/s12933-018-0762-4. Cardiovasc Diabetol. 2018. PMID: 30170598 Free PMC article. Review.
-
Comparison between distinct insulin resistance indices in measuring the development of hypertension: The China Health and Nutrition Survey.Front Cardiovasc Med. 2022 Oct 6;9:912197. doi: 10.3389/fcvm.2022.912197. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36277749 Free PMC article.
-
Insulin resistance and cardiovascular disease.J Clin Invest. 2000 Aug;106(4):453-8. doi: 10.1172/JCI10762. J Clin Invest. 2000. PMID: 10953019 Free PMC article. Review. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
